PEAK BIO(PKBO) - 2024 Q1 - Quarterly Report
PEAK BIOPEAK BIO(US:PKBO)2024-08-23 20:30

WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR UNITED STATES SECURITIES AND EXCHANGE COMMISSION For the transition period from _______________ to _______________ Commission File Number: 001-39951 Peak Bio, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 85-2448157 (State or other jurisdiction of incorporation or organization) 4900 Hopyard Road., Suite 100 ...